ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

April 27, 2007

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

New Treatment Projects Get Go-Ahead; Groups Competition To Be Increased, VA Studies Face Cut

November 4, 1977